Europe Neurostimulation Market Trends

Statistics for the 2023 & 2024 Europe Neurostimulation market trends, created by Mordor Intelligence™ Industry Reports. Europe Neurostimulation trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Market Trends of Europe Neurostimulation Industry

This section covers the major market trends shaping the Europe Neurostimulation Devices Market according to our research experts:

Parkinson’s Disease Segment is expected to be the Fastest Growing Segment

With the growing aging population and increasing prevalence of Parkinson's disease, the market is expected to witness a high growth rate. Parkinson's syndrome is one of the most common neurological diseases found in Germany. It is found to be affecting the older population, and among people aged above 65 years, the prevalence is 1,800 per 100,000. Therefore, in Germany, the number of patients is likely to increase in the future. Furthermore, Europe has a growing aging population. For instance, according to the Fondation de France, one in five French person is over 60 years old, and in 2050 one in three will be. Therefore age-associated diseases are assuming ever-greater proportions. Parkinson’s disease currently affects around 150,000 people in France. Deep Brain Stimulation (DBS) is the most commonly performed surgical treatment for Parkinson's, but it's not for everyone. DBS therapy is currently approved in many locations across the world, including the United States and Europe, as a treatment for the disabling symptoms of essential tremors, and recently, the long-standing Parkinson's disease. Thus, owing to the all above-mentioned factors, the market is expected to witness high growth over the forecast period.

Picture1_EU neuro.png

Europe Neurostimulation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)